Allergy Research Group® Introduces Sécuril® - A Novel Propionic Bacteria that Renews Bifidus & Protects the Gut*
ALAMEDA, California, USA, December 1, 2008—Allergy Research Group®, Inc. today announced the release of Sécuril®, an exciting new probiotic/prebiotic innovation for gut health.*
Sécuril® contains a special probiotic bacteria found in food called Propionibacterium freudenreichii (PF), which provides a proven bifidobacteria growth factor called DHNA (1,4-dihydroxy-2-napthoic acid).
Sécuril® represents a new alternative to bifidobacteria supplements. Bifidobacteria are the predominant flora of the large intestine, and the healthy human gut hosts a very personal profile of bifidobacteria strains. Each person possesses a unique combination of these strains for optimal health. Bifidus supplements currently on the market can’t duplicate the mixture of strains that nature has endowed for each person. Sécuril® is the only probiotic formula that helps the body optimize its own unique blend of bifidobacteria.*
Another benefit of Sécuril® is that it produces short chain fatty acids. These fatty acids, including propionic acid, have powerful protective effects in the intestinal tract.* Propionic acid can also serve as food for bifidobacteria.
Research done in Japan demonstrated that PF enhances gut motility, increases bifidobacteria, and lowers putrefactive by-products of digestion.* In other research, four out of five subjects who started the study with either diarrhea or constipation, wished to continue taking PF.*
Sécuril® promotes normal bowel transit times, and helps balance and normalize overall bowel function.*
To learn more about Allergy Research Group® and Sécuril®, visit www.allergyresearchgroup.com.
# # #
|
